EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells

Anne-Marie W Turner iD, Frances M Bashore iD, Shane D Falcinelli, Joshua A Fox, Alana L Keller, Anthony D Fenton, Renee F Geyer, Brigitte Allard, Jennifer L Kirchherr, Nancie M Archin iD, Lindsey I James, David M Margolis iD

Journal of Virology · 2025

DOI: 10.1128/jvi.01777-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Anne-Marie W Turner und 11 weiteren Autor:innen. Beteiligte Einrichtung: UNC HIV Cure Center, University of North Carolina, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Transcription Factors, Virus Latency, CD4-Positive T-Lymphocytes, Virus Activation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDA NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV cure strategies that aim to induce viral reactivation for immune clearance leverage latency reversal agents to modulate host pathways which directly or indirectly facilitate viral reactivation. Inhibition of bromo and extra-terminal domain (BET) family member BRD4 reverses HIV latency, but enthusiasm for the use of BET inhibitors in HIV cure studies is tempered by concerns over inhibition of other BET family members and dose-limiting toxicities in oncology trials. Here, we evaluated the potential for bivalent chemical degraders targeted to the BET family as alternative latency reversal agents. We observed that despite highly potent and selective BRD4 degradation in primary CD4+ T-cells from ART-suppressed donors, BRD4 degraders failed to induce latency reversal as compared to BET inhibitors. Furthermore, BRD4 degraders failed to mimic previously observed synergistic HIV reactivation between BET inhibitors and an activator of the non-canonical NF-κB pathway. Mechanistic investigation of this discrepancy revealed that latency reversal by BET inhibitors is not related to the abatement of competition between Tat and BRD4 for P-TEFb, but rather the ability of BRD4 to disrupt 7SK and increase the levels of free P-TEFb. This activity is dependent on the shift of BRD4 from chromatin-bound to soluble and retargeting of P-TEFb to chromatin, which is dependent on intact BRD4 but independent of the bromodomains. IMPORTANCE Multiple factors and pathways contribute to the maintenance of HIV latency, including bromo and extra-terminal domain (BET) family member BRD4. While small molecule inhibitors of the BET family result in latency reversal, enthusiasm for the use of BET inhibitors in HIV cure is limited due to toxicity concerns. We examined BRD4-selective chemical degraders as alternatives to BET inhibitors but found two robust degraders failed to induce latency reversal. We observed key differences in the ability of BET inhibitors versus BET degraders to disrupt P-TEFb, a key cellular activator of transcription and a complex required for HIV reactivation. We present a new model for the role of BRD4 in HIV latency and propose that BRD4 be reconsidered as an activator rather than a repressor of HIV transcription in the context of HIV cure strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsVirus LatencyCD4-Positive T-LymphocytesVirus ActivationPositive Transcriptional Elongation Factor BCell Cycle ProteinsHIV-1HIV InfectionsNuclear ProteinsHumansNF-kappa BBromodomain Containing Proteins

Stichwörter der Autor:innen

BRD4HIVP-TEFbchemical degraderslatency reversal

Substanzen

Transcription FactorsBRD4 protein, humanPositive Transcriptional Elongation Factor BCell Cycle ProteinsNuclear ProteinsNF-kappa BBromodomain Containing Proteins

Autor:innen und Institutionen

  • UNC HIV Cure Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Division of Infectious Diseases, Department of Medicine, University of North Carolina School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina…
  • Department of Microbiology and Immunology, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Anne-Marie W Turner, Frances M Bashore, Nancie M Archin, David M Margolis

Förderung

  • NIAID NIH HHS
  • NIDA NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute on Drug Abuse

Zitieren

APA

Turner, A. M. W., Bashore, F. M., Falcinelli, S. D., Fox, J. A., Keller, A. L., Fenton, A. D., Geyer, R. F., Allard, B., Kirchherr, J. L., Archin, N. M., James, L. I., & Margolis, D. M. (2025). BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells. Journal of Virology. https://doi.org/10.1128/jvi.01777-24

Vancouver

Turner AMW, Bashore FM, Falcinelli SD, Fox JA, Keller AL, Fenton AD, et al. BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells. Journal of Virology. 2025. doi:10.1128/jvi.01777-24

BibTeX
@article{Turner2025,
  author = {Turner, Anne-Marie W and Bashore, Frances M and Falcinelli, Shane D and Fox, Joshua A and Keller, Alana L and Fenton, Anthony D and Geyer, Renee F and Allard, Brigitte and Kirchherr, Jennifer L and Archin, Nancie M and James, Lindsey I and Margolis, David M},
  title = {BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.01777-24}
}
Kostenlos starten →